PMDD· 🌩️ The Dark Window

Your brain doesn't react to progesterone the same way everyone else's does.

The same hormonal fluctuation every woman experiences in the luteal phase hits PMDD differently. Progesterone metabolizes into allopregnanolone — a neurosteroid that normally calms the brain by acting on GABA-A receptors. In PMDD, sensitivity to allopregnanolone is paradoxically inverted: the same molecule that should calm instead activates. The result is mood dysregulation, rage, despair, and irritability that lift the moment your period starts.

The Dark Window targets the three systems that define PMDD: calcium deficiency (the most replicated nutritional finding in PMDD), the serotonin dimension (which saffron and B6 address), and the GABA-A sensitivity window (which magnesium and L-theanine support in the late-luteal phase). Vitex (chasteberry) reduces LH-driven progesterone spikes that amplify the allopregnanolone surge.

Build my profile — freeSee your pack ↓

Free to start · from $49/mo with delivery · NSF tested · 100% vegan

“Thys-Jacobs et al.'s 1998 RCT in the American Journal of Obstetrics and Gynecology (n=497) remains the largest calcium trial in PMDD: 1,200mg calcium daily reduced total PMDD symptom scores by 48% over three menstrual cycles versus placebo. Calcium's mechanism is distinct from serotonin — it addresses the mood-regulating role of calcium in nerve signal transmission and its documented deficiency pattern in women with PMDD. Epperson et al. (2002, Archives of General Psychiatry) confirmed the inverse GABA-A sensitivity response to allopregnanolone in PMDD, establishing the neurobiological basis: PMDD is not psychological amplification of PMS — it is a distinct neuroendocrine sensitivity disorder. SSRI response within hours (not weeks) in PMDD further confirms that the serotonin system is already primed and simply needs the right signal.”

Thys-Jacobs S et al., Am J Obstet Gynecol, 1998 · Epperson CN et al., Arch Gen Psychiatry, 2002

YOUR PROFILE

🌩️

The Dark Window

PMDD

WHAT'S IN YOUR PACK

Calcium (carbonate + citrate blend)1200mg
The 1998 Thys-Jacobs RCT is the most replicated nutritional finding in PMDD: 1,200mg/day over three cycles reduced mood, food craving, pain, and water retention scores by 48% versus placebo. Mechanism: PMDD is associated with secondary hyperparathyroidism and impaired calcium regulation — supplementation corrects the deficiency that amplifies hormonal sensitivity. Split the dose (600mg morning, 600mg evening) for maximum absorption. The most important ingredient to start with.
Vitex agnus-castus (chasteberry)20mg vitexin equivalent
Vitex acts on dopamine D2 receptors to suppress excess LH, reducing the progesterone surge that triggers allopregnanolone production. Schellenberg 2001 (BMJ, n=178) found significant improvement in PMDD symptoms versus placebo. Most effective at the source: reducing the amplitude of the luteal progesterone spike rather than trying to manage downstream neurological effects. Takes 3 menstrual cycles for full effect.
Saffron (affron extract)30mg
Akhondzadeh et al. 2005 (BJOG): 30mg affron daily significantly improved PMDD-related mood symptoms over two cycles in a placebo-controlled trial. Mechanism: safranal and crocin inhibit serotonin reuptake and reduce dopamine degradation. The serotonin component of PMDD responds to affron faster than to SSRIs — many women notice changes within the first cycle. Do not combine with SSRIs or MAOIs without prescriber guidance.
Magnesium glycinate400mg
Facchinetti et al. 1991 (Obstet Gynecol): 360mg magnesium in the luteal phase significantly reduced mood severity scores in PMS/PMDD. Magnesium is a required cofactor for GABA receptor function; in the late-luteal window when allopregnanolone is withdrawing, maintaining GABA tone is critical. Glycinate form provides the highest CNS bioavailability without GI effects. Take in the evening, starting at day 14.
Vitamin B6 (P5P)50mg
Wyatt et al. 1999 (BMJ) systematic review: B6 significantly outperformed placebo for premenstrual mood symptoms across multiple trials. B6 is a direct cofactor in serotonin synthesis (glutamic acid decarboxylase pathway) and in the metabolism of progesterone to less neurologically active forms. P5P (pyridoxal-5-phosphate) is the active form that bypasses hepatic activation. Field et al. 2022 (n=478) confirmed 100mg B6 reduces anxiety and depression.
L-theanine200mg
L-theanine promotes GABA activity and alpha-wave brain states — the calm-alert pattern that PMDD's neurological activation disrupts. Kimura et al. 2007: 200mg significantly reduced physiological anxiety markers. In PMDD, this is a bridge ingredient — it works within 30–60 minutes in the acute symptomatic window. Particularly useful on the worst days (typically days 24–27) before the mood lift that comes with bleeding.

Do not combine saffron with SSRIs, SNRIs, or MAOIs without prescriber guidance — serotonergic overlap risk. Vitex (chasteberry) is not appropriate during pregnancy or while on hormonal birth control. Calcium: split dose for absorption (600mg morning, 600mg evening). Begin the full pack at day 14 of your cycle for maximum luteal-phase coverage.

“I spent fifteen years believing I had a personality problem. Then my therapist mentioned PMDD. The pattern was exactly right — I'd be fine, then I'd become someone else for ten days, then I'd be fine again the moment my period started. The Dark Window pack, especially the calcium and saffron combination, reduced the severity of those ten days significantly. Not gone, but manageable in a way nothing else had achieved.”

Rachel H., 34
PMDD diagnosis at 32 · previously misdiagnosed as BPD · London

COMMON QUESTIONS

Build your
The Dark Window profile.

Two minutes. Completely free. Your profile and pack preview are yours before you ever enter a card.

Begin free →

FOUNDING MEMBERS

500 spots. Price locked forever. Essential $39/mo, Full Protocol $69/mo — permanent founding rate.

RELATED PROFILES

Anxiety →Depression →Perimenopause →All 33 profiles →